Emyria (ASX:EMD) Share Price and News - StockTrack

Market Cap (1-Jul) $17,120,628 (923rd)	Close (30-Jun) $0.125 0 (0%)	Volume (30-Jun) 0	Shortsold (17-Apr) 8,415 (0.00%) (600th)
52w High $0.058	52w Low $0.021	P/E -	EPS 0

	Subject
	EMD EMD Ann: Proposed issue of securities - EMD
	1 (current) 2 3
	EMD EMD Ann: Emyria completes $3m placement
	EMD EMD Ann: Trading Halt
	EMD EMD Ann: Results of Meeting
	EMD EMD Ann: Emyria and UWA expand unique MDMA-inspired analogue library
	EMD EMD Ann: MDMA-inspired drug discovery presentation
	EMD EMD Ann: Emyria Investor Webinar - October 13
	EMD EMD Ann: Emyria expands clinical sites for EMD-RX5 Phase 3 trial
	EMD EMD Ann: Letter to Shareholders - Annual General Meeting
	EMD EMD Ann: Notice of Annual General Meeting/Proxy Form
	EMD EMD Ann: Emyria commences US preclinical program for MDMA library
	EMD EMD Ann: Annual General Meeting
	EMD EMD Ann: Annual Report to Shareholders
	EMD EMD Ann: Appendix 4G
	EMD EMD Ann: Appendix 4E and Annual Report
	EMD EMD Ann: Positive results received for Emyrias MDMA-inspired program
	EMD EMD Ann: Notification regarding unquoted securities - EMD
	EMD EMD Ann: Emyria receives ethics approval for EMD-RX5 Phase 3 trial
	EMD EMD Ann: Preclinical studies initiated for MDMA-inspired analogues
	EMD EMD Ann: Appendix 4C - Quarterly
	EMD EMD Ann: Emyria expands drug candidate library inspired by MDMA
	EMD EMD Ann: Notification regarding unquoted securities - EMD
	EMD EMD Ann: Drug development webinar presentation
	EMD EMD Ann: Emyria expands MDMA analogue program with UWA
	EMD EMD Ann: Emyria Investor Webinar, June 1st
	EMD EMD Ann: EMD-RX5 demonstrates excellent safety and bioavailability
	EMD EMD Ann: Trading Halt
	EMD EMD Ann: Further positive MDMA analogue screening results received
	EMD EMD Ann: Appendix 4C - Quarterly
	EMD EMD Ann: Results of Meeting
	EMD EMD Ann: Change of Director's Interest Notice MW
	EMD EMD Ann: EMD-RX5 Dosing to Complete for Phase 1 Clinical Trial
	EMD EMD Ann: Clinitrials to lead multi-site Phase 3 trial for EMD-RX5
	EMD EMD Ann: Dosing Commences For EMD-RX5 Phase 1 Human Clinical Trial
	EMD EMD Ann: Broker Briefing Presentation
	EMD EMD Ann: Emyria to present webinar, March 24th
	EMD EMD Ann: Letter to Shareholders - Adjourned General Meeting
	EMD EMD Ann: Addendum to Notice of Meeting and Proxy Form
	EMD EMD Ann: Emyria launches second ultra-pure CBD capsule
	EMD EMD Ann: EMD-RX5 program advancing Phase 1 clinical trials underway
	EMD EMD Ann: Recruitment commenced for EMD-RX5 Phase 1 Study
	EMD EMD Ann: Hidden Gems Webinar Presentation
	EMD EMD Ann: Ethics approval received for EMD-RX5 Phase 1 Study
	EMD EMD Ann: Emyria to present at Hidden Gems Webinar March 4th
	EMD EMD Ann: Half Yearly Report and Accounts
	EMD EMD Ann: Emyria grows its novel MDMA-analogue library
	EMD EMD Ann: General Meeting Adjourned - Letter to Shareholders
	EMD EMD Ann: Application for quotation of securities - EMD
	EMD EMD Ann: Release of securities from escrow
	EMD EMD Ann: Notice under section 708A(5)(e) of the Corporations Act

Similar Companies

Estia Health

EHE

Japara Healthcare

JHC

Monash IVF Group

MVF

1300SMILES

ONT

Pacific Smiles Group

PSQ

Regis Healthcare

REG

Ramsay Health Care

RHC

Virtus Health

VRT

End of Day Prices

Date	Close	Volume	Change
30-Jun	$0.03	4,967,905	+0.00 (3.70%)
27-Jun	$0.03	5,758,356	+0.00 (8.00%)
26-Jun	$0.03	7,507,729	0.00 (7.41%)
24-Jun	$0.03	1,203,134	0.00 (3.57%)
23-Jun	$0.03	1,093,409	0.00 (3.45%)
20-Jun	$0.03	4,617,930	0.00 (0.00%)
19-Jun	$0.03	11,467,856	+0.00 (3.57%)
18-Jun	$0.03	14,772,303	+0.00 (12.00%)
16-Jun	$0.03	0	0.00 (0.00%)
13-Jun	$0.03	1,627,347	+0.00 (8.70%)
12-Jun	$0.02	274,691	0.00 (11.54%)
06-Jun	$0.03	237,174	+0.00 (8.33%)
05-Jun	$0.02	84,487	0.00 (0.00%)
04-Jun	$0.02	726,986	0.00 (7.69%)
03-Jun	$0.03	1,099,560	0.00 (7.14%)
6 up, 6 down, and 3 flat days

High -	Low -	Trades -	Turnover $0	Volume 0
2 July 2025 at 10:07pm

High -	Low -	Trades -	Turnover $0	Volume 0
2 July 2025 at 10:07pm

Emyria Health Care

$0.125 (0%)

$0.125 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices